Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 152

1.

Additional factors that could improve cost-effectiveness of pharmacogenetic-guided dosing in warfarin therapy.

Geisler BP, Levin-Scherz JK.

Ann Intern Med. 2009 Jul 7;151(1):71; author reply 71. No abstract available.

PMID:
19581651
[PubMed - indexed for MEDLINE]
2.

Cost-effectiveness of using pharmacogenetic information in warfarin dosing for patients with nonvalvular atrial fibrillation.

Eckman MH, Rosand J, Greenberg SM, Gage BF.

Ann Intern Med. 2009 Jan 20;150(2):73-83.

PMID:
19153410
[PubMed - indexed for MEDLINE]
3.

Cost-effectiveness of genotype-guided warfarin dosing for patients with atrial fibrillation.

Patrick AR, Avorn J, Choudhry NK.

Circ Cardiovasc Qual Outcomes. 2009 Sep;2(5):429-36. doi: 10.1161/CIRCOUTCOMES.108.808592. Epub 2009 Jul 21.

PMID:
20031873
[PubMed - indexed for MEDLINE]
Free Article
4.

Cost-effectiveness of genotype-guided warfarin therapy for anticoagulation in elderly patients with atrial fibrillation.

Leey JA, McCabe S, Koch JA, Miles TP.

Am J Geriatr Pharmacother. 2009 Aug;7(4):197-203. doi: 10.1016/j.amjopharm.2009.07.002.

PMID:
19766951
[PubMed - indexed for MEDLINE]
5.

Cost-effectiveness of pharmacogenetic-guided dosing of phenprocoumon in atrial fibrillation.

Verhoef TI, Redekop WK, Veenstra DL, Thariani R, Beltman PA, van Schie RM, de Boer A, Maitland-van der Zee AH; EU-PACT Group.

Pharmacogenomics. 2013 Jun;14(8):869-83. doi: 10.2217/pgs.13.74.

PMID:
23746182
[PubMed - indexed for MEDLINE]
6.

Potential clinical and economic outcomes of CYP2C9 and VKORC1 genotype-guided dosing in patients starting warfarin therapy.

You JH, Tsui KK, Wong RS, Cheng G.

Clin Pharmacol Ther. 2009 Nov;86(5):540-7. doi: 10.1038/clpt.2009.104. Epub 2009 Jul 1.

PMID:
19571807
[PubMed - indexed for MEDLINE]
7.

Management of warfarin in atrial fibrillation.

Ford PW, Close A.

Med J Aust. 2007 Sep 17;187(6):371; author reply 371. No abstract available.

PMID:
17874992
[PubMed - indexed for MEDLINE]
8.

Letter regarding article by Hylek et al, "Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation".

Ono A, Kawamura I, Fujita T.

Circulation. 2007 Nov 13;116(20):e538. No abstract available.

PMID:
17998467
[PubMed - indexed for MEDLINE]
Free Article
9.

Net clinical benefit of warfarin: extending the reach of antithrombotic therapy for atrial fibrillation.

Fuster V, Chinitz JS.

Circulation. 2012 May 15;125(19):2285-7. doi: 10.1161/CIRCULATIONAHA.112.102319. Epub 2012 Apr 18. No abstract available.

PMID:
22514253
[PubMed - indexed for MEDLINE]
Free Article
10.

Should we be applying warfarin pharmacogenetics to clinical practice? No, not now.

Rosove MH, Grody WW.

Ann Intern Med. 2009 Aug 18;151(4):270-3, W95.

PMID:
19687493
[PubMed - indexed for MEDLINE]
11.

The use of practitioner education and a warfarin monitoring service to improve anticoagulation practices.

Gaughan GL.

Arch Intern Med. 2000 Aug 14-28;160(15):2401-2; author reply 2403. No abstract available.

PMID:
10927751
[PubMed - indexed for MEDLINE]
12.

Age adjusted warfarin.

Gallo JH.

Aust N Z J Med. 2000 Aug;30(4):512. No abstract available.

PMID:
10985522
[PubMed - indexed for MEDLINE]
13.

[Anticoagulant therapy of atrial fibrillation].

Onshuus E.

Tidsskr Nor Laegeforen. 2002 Apr 10;122(9):951-2; author reply 952. Norwegian. No abstract available.

PMID:
12082843
[PubMed - indexed for MEDLINE]
Free Article
14.

Treatment of atrial fibrillation with warfarin in Rhode Island.

Gifford DR, Silverman LR.

Med Health R I. 2000 May;83(5):156-7. No abstract available.

PMID:
10874820
[PubMed - indexed for MEDLINE]
15.

Pharmacoeconomic evaluation of warfarin pharmacogenomics.

You JH.

Expert Opin Pharmacother. 2011 Feb;12(3):435-41. doi: 10.1517/14656566.2011.521153. Epub 2011 Jan 14. Review.

PMID:
21231897
[PubMed - indexed for MEDLINE]
16.

[Warfarin treatment in atrial fibrillation].

Meland E.

Tidsskr Nor Laegeforen. 2006 Sep 21;126(18):2409; author reply 2409-10. Norwegian. No abstract available.

PMID:
16998561
[PubMed - indexed for MEDLINE]
Free Article
17.

Delivering effective anticoagulation in atrial fibrillation: we can do better!

Verma S.

Heart Rhythm. 2008 Oct;5(10):1373-4. doi: 10.1016/j.hrthm.2008.08.009. Epub 2008 Aug 17. No abstract available.

PMID:
18929321
[PubMed - indexed for MEDLINE]
18.

A unique warfarin therapy in Japan.

Mitamura H.

Circ J. 2011;75(9):2048-9. Epub 2011 Aug 3. No abstract available.

PMID:
21817809
[PubMed - indexed for MEDLINE]
Free Article
19.

Oral anticoagulant therapy for patients with atrial fibrillation--an update.

Hylek EM.

Thromb Res. 2008;123 Suppl 1:S46-9. doi: 10.1016/j.thromres.2008.08.016. Epub 2008 Sep 21. Review. No abstract available.

PMID:
18809205
[PubMed - indexed for MEDLINE]
20.

Study suggests limiting use of aspirin plus warfarin.

[No authors listed]

Harv Heart Lett. 2007 May;17(9):6. No abstract available.

PMID:
17526074
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk